AMRN
Drug Manufacturers - General · Healthcare
CFO
Equibles does not estimate personal net worth.
Thomas Reilly was last confirmed as CFO at Amarin Corp Plcuk (AMRN) in a filing dated March 4, 2024. The proxy statement of Amarin Corp Plcuk reports total compensation of $1,114,760 for Thomas Reilly in fiscal 2024, including a base salary of $471,334. Disclosed compensation is on record for 3 fiscal years. Thomas Reilly has spoken on 1 earnings call across 1 company, most recently for Amarin Corp Plcuk on May 1, 2024. The companies whose calls Thomas Reilly spoke on are classified in the Healthcare sector.
“Today, I am reporting details on our financial performance for the first quarter of 2024.”
Start not stated–2024-03-04
Last confirmed by a filing; no departure on record
AMRN
Drug Manufacturers - General · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Amarin Corp Plcuk (AMRN) | Former Executive Vice President, Chief Financial Officer and Global Head of HR | $471,334 | $1,114,760 |
| 2023 | Amarin Corp Plcuk (AMRN) | Former Executive Vice President, Chief Financial Officer and Global Head of HR | $550,083 | $2,201,960 |
| 2022 | Amarin Corp Plcuk (AMRN) | Former Executive Vice President, Chief Financial Officer and Global Head of HR | $280,367 | $1,015,495 |